Interactions Between Amyloid-β and Tau Fragments Promote Aberrant Aggregates: Implications for Amyloid Toxicity

Overview

Journal J Phys Chem B

Publisher American Chemical Society

Specialty Chemistry

Date 2014 Aug 26

PMID 25153942

Citations 26

Authors

Thanh D Do

Nicholas J Economou

Ali Chamas

Steven K Buratto

Joan-Emma Shea

Michael T Bowers

Affiliations

Soon will be listed here.

Abstract

We have investigated at the oligomeric level interactions between Aβ(25-35) and Tau(273-284), two important fragments of the amyloid-β and Tau proteins, implicated in Alzheimer's disease. We are able to directly observe the coaggregation of these two peptides by probing the conformations of early heteroligomers and the macroscopic morphologies of the aggregates. Ion-mobility experiment and theoretical modeling indicate that the interactions of the two fragments affect the self-assembly processes of both peptides. Tau(273-284) shows a high affinity to form heteroligomers with existing Aβ(25-35) monomer and oligomers in solution. The configurations and characteristics of the heteroligomers are determined by whether the population of Aβ(25-35) or Tau(273-284) is dominant. As a result, two types of aggregates are observed in the mixture with distinct morphologies and dimensions from those of pure Aβ(25-35) fibrils. The incorporation of some Tau into β-rich Aβ(25-35) oligomers reduces the aggregation propensity of Aβ(25-35) but does not fully abolish fibril formation. On the other hand, by forming complexes with Aβ(25-35), Tau monomers and dimers can advance to larger oligomers and form granular aggregates. These heteroligomers may contribute to toxicity through loss of normal function of Tau or inherent toxicity of the aggregates themselves.

Citing Articles

Diosmin ameliorates inflammation, apoptosis and activates PI3K/AKT pathway in Alzheimer's disease rats.

Wang Y, Ye X, Su W, Yan C, Pan H, Wang X Metab Brain Dis. 2024; 39(7):1405-1415.

PMID: 39105973 DOI: 10.1007/s11011-024-01388-7.

A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization.

De Leiris N, Perret P, Lombardi C, Gozel B, Chierici S, Millet P J Transl Med. 2024; 22(1):163.

PMID: 38365700 PMC: 10870657. DOI: 10.1186/s12967-024-04987-1.

Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism.

Samman W, Selim S, El Fayoumi H, El-Sayed N, Mehanna E, Hazem R Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242536 PMC: 10223357. DOI: 10.3390/ph16050753.

Network pharmacology reveals that Berberine may function against Alzheimer's disease via the AKT signaling pathway.

Wei W, Yao J, Zhang T, Wen J, Zhang Z, Luo Y Front Neurosci. 2023; 17:1059496.

PMID: 37214397 PMC: 10192713. DOI: 10.3389/fnins.2023.1059496.

Natural IgG antibodies to β amyloid are decreased in patients with Parkinson's disease.

Paganelli R, Paganelli A, Pawelec G, Di Iorio A Immun Ageing. 2023; 20(1):13.

PMID: 36906630 PMC: 10007830. DOI: 10.1186/s12979-023-00336-w.

References

Hess B, Kutzner C, van der Spoel D, Lindahl E . GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput. 2015; 4(3):435-47. DOI: 10.1021/ct700301q. View

Laganowsky A, Liu C, Sawaya M, Whitelegge J, Park J, Zhao M . Atomic view of a toxic amyloid small oligomer. Science. 2012; 335(6073):1228-31. PMC: 3959867. DOI: 10.1126/science.1213151. View

Clementi M, Marini S, Coletta M, Orsini F, Giardina B, Misiti F . Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: Role of the redox state of methionine-35. FEBS Lett. 2005; 579(13):2913-8. DOI: 10.1016/j.febslet.2005.04.041. View

Maeda S, Sahara N, Saito Y, Murayama M, Yoshiike Y, Kim H . Granular tau oligomers as intermediates of tau filaments. Biochemistry. 2007; 46(12):3856-61. DOI: 10.1021/bi061359o. View

Pike C, Kosmoski J, Cribbs D, Glabe C, Cotman C . Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem. 1995; 64(1):253-65. DOI: 10.1046/j.1471-4159.1995.64010253.x. View

Bleiholder C, Do T, Wu C, Economou N, Bernstein S, Buratto S . Ion mobility spectrometry reveals the mechanism of amyloid formation of Aβ(25-35) and its modulation by inhibitors at the molecular level: epigallocatechin gallate and scyllo-inositol. J Am Chem Soc. 2013; 135(45):16926-37. DOI: 10.1021/ja406197f. View

Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe D . Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A. 2011; 108(14):5819-24. PMC: 3078381. DOI: 10.1073/pnas.1017033108. View

Tokutake T, Kasuga K, Yajima R, Sekine Y, Tezuka T, Nishizawa M . Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway. J Biol Chem. 2012; 287(42):35222-35233. PMC: 3471719. DOI: 10.1074/jbc.M112.348300. View

Goux W, Kopplin L, Nguyen A, Leak K, Rutkofsky M, Shanmuganandam V . The formation of straight and twisted filaments from short tau peptides. J Biol Chem. 2004; 279(26):26868-75. DOI: 10.1074/jbc.M402379200. View

10.

Busciglio J, Lorenzo A, Yeh J, Yankner B . beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995; 14(4):879-88. DOI: 10.1016/0896-6273(95)90232-5. View

11.

Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E . Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. 2013; 32(22):2920-37. PMC: 3831312. DOI: 10.1038/emboj.2013.207. View

12.

Binder L, Guillozet-Bongaarts A, Garcia-Sierra F, Berry R . Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta. 2004; 1739(2-3):216-23. DOI: 10.1016/j.bbadis.2004.08.014. View

13.

Bleiholder C, Dupuis N, Wyttenbach T, Bowers M . Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to β-sheet in amyloid fibril formation. Nat Chem. 2011; 3(2):172-7. PMC: 3073516. DOI: 10.1038/nchem.945. View

14.

Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M . Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res. 1998; 31(4):317-23. DOI: 10.1016/s0168-0102(98)00061-3. View

15.

van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

16.

Wiltzius J, Landau M, Nelson R, Sawaya M, Apostol M, Goldschmidt L . Molecular mechanisms for protein-encoded inheritance. Nat Struct Mol Biol. 2009; 16(9):973-8. PMC: 3640378. DOI: 10.1038/nsmb.1643. View

17.

Miller Y, Ma B, Nussinov R . Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry. 2011; 50(23):5172-81. PMC: 3109766. DOI: 10.1021/bi200400u. View

18.

Giannakopoulos P, Herrmann F, Bussiere T, Bouras C, Kovari E, Perl D . Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology. 2003; 60(9):1495-500. DOI: 10.1212/01.wnl.0000063311.58879.01. View

19.

Olzscha H, Schermann S, Woerner A, Pinkert S, Hecht M, Tartaglia G . Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell. 2011; 144(1):67-78. DOI: 10.1016/j.cell.2010.11.050. View

20.

LaFerla F, Green K, Oddo S . Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci. 2007; 8(7):499-509. DOI: 10.1038/nrn2168. View